199 related articles for article (PubMed ID: 2283705)
1. [Clinical evaluation of imipenem/cilastatin sodium in infectious complications of hematological malignancies. Tohkai Research Group on Infections in Hematological Disorders].
Naito K; Kobayashi M; Okumura M; Ikeda Y; Mitomo Y; Oguri T; Tanaka M; Ohara K; Kodera Y; Ohno R
Jpn J Antibiot; 1990 Aug; 43(8):1371-80. PubMed ID: 2283705
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
Sawae Y; Niho Y; Harada M; Shibuya T; Okamura T; Asano Y; Taniguchi S; Murakawa M; Toyoshima T; Kozuru M
Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
[TBL] [Abstract][Full Text] [Related]
3. [Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders].
Hotta T; Morishima Y; Saito H; Kodera Y; Hirabayashi N; Tanaka M; Mizuno H; Suzuki H; Kato Y; Morishita Y
Jpn J Antibiot; 1991 May; 44(5):515-28. PubMed ID: 1880931
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of imipenem/cilastatin sodium against severe infections complicating hematological disorders and solid tumors].
Saito H; Furuta S; Nagata A; Yoshizawa S; Nishizawa K; Ichikawa S; Aizawa T; Yoda H; Maruyama D; Koike Y
Jpn J Antibiot; 1991 Aug; 44(8):899-911. PubMed ID: 1920815
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy with imipenem/cilastatin for severe infections accompanied by malignant hematological disorders].
Fujii Y; Inoue Y; Hiroshige Y; Kaku K; Kaneko T
Jpn J Antibiot; 1993 Mar; 46(3):259-68. PubMed ID: 8510323
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders].
Tsuda S; Nakai H; Murakami T; Seryu S; Takashima T; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Nishida K
Jpn J Antibiot; 1991 Aug; 44(8):886-98. PubMed ID: 1920814
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders].
Tsukada T; Katayama N; Kageyama S; Nishikawa M; Kobayashi T; Deguchi K; Shirakawa S; Minami N
Jpn J Antibiot; 1990 Dec; 43(12):2087-93. PubMed ID: 2086823
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic effects of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
Tatsumi N; Nin T; Sannomiya Y; Kageyama T; Ohyabu H; Akasaka K; Nasu K; Yonezawa T; Tominaga N; Kitani T
Jpn J Antibiot; 1989 May; 42(5):1065-76. PubMed ID: 2664253
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of imipenem/cilastatin sodium against severe infections complicated with hematological disorders and solid tumors].
Takemori H; Sakata Y; Ogasawara H; Haga Y; Sawada Y; Aihara M; Sasaki D; Yoshida Y; Chiba Y; Suzuki A
Jpn J Antibiot; 1989 Dec; 42(12):2566-73. PubMed ID: 2614913
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of imipenem/cilastatin sodium and fosfomycin as second-line combination chemotherapy in severe infections associated with hematologic disorders].
Tsuda S; Kuzuyama Y; Nakai H; Seriu T; Takashima T; Tanaka S; Horiike S; Taniwaki M; Misawa S; Kashima K
Jpn J Antibiot; 1993 Feb; 46(2):171-83. PubMed ID: 8331778
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group].
Fujii R; Sakata H; Inyaku F; Fujita K; Maruyama S; Yoshioka H; Hashira S; Tajima T; Nakazawa S; Sato H
Jpn J Antibiot; 1989 Apr; 42(4):953-72. PubMed ID: 2671429
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of imipenem/cilastatin sodium against infections in compromised children (malignancy, hematological disease, collagen disease)].
Nakano T; Itoh M; Sakurai M
Jpn J Antibiot; 1992 Aug; 45(8):1016-22. PubMed ID: 1433890
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in the perinatal period. A study of imipenem/cilastatin sodium in the perinatal co-research group].
Matsuda S; Suzuki M; Oh K; Ishikawa M; Soma A; Takada H; Shimizu T; Makinoda S; Fujimoto S; Chimura T
Jpn J Antibiot; 1988 Nov; 41(11):1731-41. PubMed ID: 3062205
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Matsuda S; Oh K; Tateno M; Kojima Y; Hirabayashi K; Okada E; Doko F; Kawai J
Jpn J Antibiot; 1991 Dec; 44(12):1359-67. PubMed ID: 1798070
[TBL] [Abstract][Full Text] [Related]
15. [Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders].
Sawae Y; Niho Y; Okamura T; Gondo H; Kozuru M; Uike N; Muta K; Goto T; Suehiro Y; Kumakawa M; Nishimura J; Yufu Y; Ishikura H; Yamashita S; Hisano S; Morioka E; Nakajima H; Shibuya T; Yamasaki K; Harada N; Asayama R; Hayashi S; Akashi K; Suematsu E; Kawasaki C
Jpn J Antibiot; 1996 Dec; 49(12):1049-61. PubMed ID: 9032592
[TBL] [Abstract][Full Text] [Related]
16. [A comparative study of imipenem/cilastatin sodium BID vs QID in the treatment of infections associated with hematopoietic disorders].
Sawae Y; Niho Y; Okamura T; Murakawa M; Teshima T; Fujisaki T; Ikeda K; Kozuru M; Uike N; Katsuno M
Jpn J Antibiot; 1994 Oct; 47(10):1318-28. PubMed ID: 7807693
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of imipenem/cilastatin sodium in the internal medicine].
Fukuhara H; Kusano N; Nakamura H; Kaneshima H; Irabu Y; Shimozi K; Kitukawa K; Shigeno Y; Saito A; Kakazu T
Jpn J Antibiot; 1991 Aug; 44(8):877-85. PubMed ID: 1920813
[TBL] [Abstract][Full Text] [Related]
18. [Clinical studies on imipenem/cilastatin sodium in the perinatal period].
Matsuda S; Suzuki M; Oh K
Jpn J Antibiot; 1988 Nov; 41(11):1774-7. PubMed ID: 3210307
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics and clinical efficacy of imipenem/cilastatin sodium in neonates].
Azagami S; Kusumoto Y; Oikawa T; Osano M; Shiro H; Shirai Y; Nakamura M
Jpn J Antibiot; 1988 Nov; 41(11):1704-14. PubMed ID: 3210302
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic, bacteriological and clinical studies on imipenem/cilastatin sodium in neonates].
Iwai N; Nakamura H; Miyazu M; Kasai K; Taneda Y
Jpn J Antibiot; 1989 May; 42(5):1087-101. PubMed ID: 2746858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
